The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Raw Materials
1.2.3 Viral Banks
1.2.4 Cell Banks
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 CROs and CDMOs
1.3.4 Academic and Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Perspective (2018-2029)
2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Growth Trends by Region
2.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Dynamics
2.3.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
2.3.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Drivers
2.3.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Challenges
2.3.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical and Biopharmaceutical Safety Testing Service Players by Revenue
3.1.1 Global Top Pharmaceutical and Biopharmaceutical Safety Testing Service Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue
3.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Concentration Ratio
3.4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue in 2022
3.5 Pharmaceutical and Biopharmaceutical Safety Testing Service Key Players Head office and Area Served
3.6 Key Players Pharmaceutical and Biopharmaceutical Safety Testing Service Product Solution and Service
3.7 Date of Enter into Pharmaceutical and Biopharmaceutical Safety Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical and Biopharmaceutical Safety Testing Service Breakdown Data by Type
4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical and Biopharmaceutical Safety Testing Service Breakdown Data by Application
5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2018-2029)
6.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2018-2023)
6.4 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2018-2029)
7.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2018-2029)
9.2 Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.1.4 Merck Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.2.4 Charles River Laboratories Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.2.5 Charles River Laboratories Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Detail
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.3.4 Sartorius Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.3.5 Sartorius Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.4.4 Eurofins Scientific Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.4.5 Eurofins Scientific Recent Development
11.5 SGS
11.5.1 SGS Company Detail
11.5.2 SGS Business Overview
11.5.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.5.4 SGS Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.5.5 SGS Recent Development
11.6 Q2 Solutions
11.6.1 Q2 Solutions Company Detail
11.6.2 Q2 Solutions Business Overview
11.6.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.6.4 Q2 Solutions Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.6.5 Q2 Solutions Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Detail
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.7.4 Samsung Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.7.5 Samsung Biologics Recent Development
11.8 Texcell
11.8.1 Texcell Company Detail
11.8.2 Texcell Business Overview
11.8.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.8.4 Texcell Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.8.5 Texcell Recent Development
11.9 WuXi Biologics
11.9.1 WuXi Biologics Company Detail
11.9.2 WuXi Biologics Business Overview
11.9.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.9.4 WuXi Biologics Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.9.5 WuXi Biologics Recent Development
11.10 Wuhan Canvest Biotechnology
11.10.1 Wuhan Canvest Biotechnology Company Detail
11.10.2 Wuhan Canvest Biotechnology Business Overview
11.10.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.10.4 Wuhan Canvest Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.10.5 Wuhan Canvest Biotechnology Recent Development
11.11 Centre Testing International (CTI)
11.11.1 Centre Testing International (CTI) Company Detail
11.11.2 Centre Testing International (CTI) Business Overview
11.11.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.11.4 Centre Testing International (CTI) Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.11.5 Centre Testing International (CTI) Recent Development
11.12 Suzhou Liangchen Biotechnology
11.12.1 Suzhou Liangchen Biotechnology Company Detail
11.12.2 Suzhou Liangchen Biotechnology Business Overview
11.12.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.12.4 Suzhou Liangchen Biotechnology Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.12.5 Suzhou Liangchen Biotechnology Recent Development
11.13 JADE Biomedical
11.13.1 JADE Biomedical Company Detail
11.13.2 JADE Biomedical Business Overview
11.13.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.13.4 JADE Biomedical Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.13.5 JADE Biomedical Recent Development
11.14 Standard Testing Group
11.14.1 Standard Testing Group Company Detail
11.14.2 Standard Testing Group Business Overview
11.14.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.14.4 Standard Testing Group Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.14.5 Standard Testing Group Recent Development
11.15 Sino Tech World Biologicals
11.15.1 Sino Tech World Biologicals Company Detail
11.15.2 Sino Tech World Biologicals Business Overview
11.15.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.15.4 Sino Tech World Biologicals Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.15.5 Sino Tech World Biologicals Recent Development
11.16 CAS Testing Technical Services
11.16.1 CAS Testing Technical Services Company Detail
11.16.2 CAS Testing Technical Services Business Overview
11.16.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.16.4 CAS Testing Technical Services Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.16.5 CAS Testing Technical Services Recent Development
11.17 NTEK
11.17.1 NTEK Company Detail
11.17.2 NTEK Business Overview
11.17.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.17.4 NTEK Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.17.5 NTEK Recent Development
11.18 Sino Biological
11.18.1 Sino Biological Company Detail
11.18.2 Sino Biological Business Overview
11.18.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.18.4 Sino Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.18.5 Sino Biological Recent Development
11.19 Miracle Points
11.19.1 Miracle Points Company Detail
11.19.2 Miracle Points Business Overview
11.19.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.19.4 Miracle Points Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.19.5 Miracle Points Recent Development
11.20 Suzhou Cefety Bioscience
11.20.1 Suzhou Cefety Bioscience Company Detail
11.20.2 Suzhou Cefety Bioscience Business Overview
11.20.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.20.4 Suzhou Cefety Bioscience Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.20.5 Suzhou Cefety Bioscience Recent Development
11.21 Zhejiang Hengyu Biological
11.21.1 Zhejiang Hengyu Biological Company Detail
11.21.2 Zhejiang Hengyu Biological Business Overview
11.21.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Introduction
11.21.4 Zhejiang Hengyu Biological Revenue in Pharmaceutical and Biopharmaceutical Safety Testing Service Business (2018-2023)
11.21.5 Zhejiang Hengyu Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details